Clinical Trial Update: Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration [NA]

View source ↗

Summary

A clinical trial evaluating intravitreal cell injections for dry age-related macular degeneration has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Age-related Macular Degeneration

Snippet

Sponsor: Bioheart, Inc. | Conditions: Dry Macular Degeneration | NA | Status: WITHDRAWN